University of California, San Diego
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of California, San Diego sits in the top decile of US sponsors by registered trial count (#43 of 15,742 sponsors by registered trial count).
University of California, San Diego: 775 sponsored US clinical trials, 143 recruiting.
University of California, San Diego sponsors 775 registered US clinical trials on ClinicalTrials.gov, 143 of them currently recruiting, and 499 completed. 104 of these trials are in Phase 3-4 (later-stage) and 170 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Anorexia Nervosa, with 10 trials.
Top-decile sponsor footprint
University of California, San Diego ranks in the top decile of sponsors by registered trial count (#43 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
499 of 553 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (90.2%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
775 total, page 10 of 16
Effect of Packaging on Smoking Perceptions and Behavior
NCT02676193
Continuous TAP Blocks: Relative Effects of a Basal Infusion vs. Repeated Bolus Doses
NCT02662023
Agitated Saline, Albumin, or Propofol-albumin Mixture for Enhanced Contrast in TEE Examinations
NCT02613052
Antibiotic Prophylaxis With Routine Ureteral Stent Removal
NCT02944825
Elvitegravir (EVG) Cerebrospinal Fluid (CSF) Pharmacokinetics in HIV-Infected Individuals
NCT02251236
Aramchol for HIV-associated Nonalcoholic Fatty Liver Disease and Lipodystrophy
NCT02684591
Endourology Disease Group Excellence (EDGE) Consortium: Antibiotics (Abx) for Percutaneous Nephrolithotomy (PCNL) Part 2
NCT02829060
Impact of Hepatitis C Virus Therapy on Central Nervous System Outcomes
NCT02650024
Training Attention and Eye Movement in ASD
NCT02403817
Lymphoseek as Lymphoid Tissue Targeting Agent in Patients With Cancer of the Endometrium
NCT02589366
Determination of Upper Airway Collapsibility During Routine CPAP Titration
NCT02566278
Testing the Leadership and Organizational Change for Implementation (LOCI) Intervention
NCT03042832
Long-pulsed 1064 nm Nd:YAG Laser Treatment of Basal Cell Carcinoma
NCT02662244
PACIFIC: Providing Adults Collaborative Interventions For Ideal Changes
NCT02516839
Postoperative Chemotherapy in High-Grade Appendiceal Adenocarcinoma With Peritoneal Carcinomatosis
NCT02420509
Ibrutinib in Combination With GA101 (Obinutuzumab) in Previously Untreated Chronic Lymphocytic Leukemia (CLL) Patients.
NCT02315768
Effects of Upper Airway Muscle Training on OSA
NCT02502942
Effects of Catheter Location on Postoperative Analgesia for Continuous Adductor Canal and Popliteal-Sciatic Nerve Blocks
NCT02523235
Effect of Mode of Transport Ventilation on Respiratory Parameters After Cardiac Surgery
NCT02740075
The Lean Living Study
NCT02501889
Pathophysiology of the Upper Airway in Patients With COPD and Concomitant OSA
NCT02567448
Peer Empowerment Program for Physical Activity in Low Income and Minority Seniors
NCT02405325
Dietary Treatment Study of Pediatric NAFLD
NCT02513121
The Effect of Melatonin on Sleep and Ventilatory Control in Obstructive Sleep Apnea
NCT02484300
Potential Mechanism of Exercise Impairment in OSA
NCT02505594
Developing a Text-Message Enhanced Physical Activity Intervention for Latino Men
NCT02512419
Tracking Physical Activity Throughout Chemotherapy for Breast Cancer
NCT03041545
Evaluation of the CIRCA Monitoring System in Prevention of Esophageal Lesions Following RFCA
NCT02467166
Effects of Epicatechin on Statins for Mitochondrial Dysfunction and Impaired Exercise Capacity
NCT02490527
University of California, San Diego (UCSD) Suramin Autism Treatment-1 (SAT1) Trial
NCT02508259
Paracervical Block for Pain Control With Osmotic Dilator Placement
NCT02354092
The Effects of Journaling on Health-Related Mood and Clinical Outcomes in Post-MI Patients
NCT02481544
U.S. CTEPH Registry
NCT02429284
Reproductive Health Survivorship Care Plan
NCT02667626
Evaluation of the Amigo Robotic System for Ablation of the Cavo-Tricuspid Isthmus
NCT02467179
A Randomized Trial of Preoperative Prophylactic Antibiotics Prior to Kidney Stone Surgery (Percutaneous Nephrolithotomy [PCNL])
NCT02384200
Study of Molecular Profile-Related Evidence to Determine Individualized Therapy for Advanced or Poor Prognosis Cancers
NCT02534675
Outcomes of a Skill-Based Program for Eating Disorders
NCT02852538
Validation of the Short-term Antimicrobial Action of Transplanted Bacteria
NCT01959113
Effect of Vitamin D Supplementation on Bone Turnover Markers During PrEP in MSM
NCT02367599
Noninvasive Measurement of CO Using Impedance Cardiography in Patients With CHD
NCT02326649
A Comparison of Bed Rest Versus Moderate Activity in Preterm Premature Rupture of Membranes (PPROM)
NCT02327637
Anakinra in Infants and Children With Coronary Artery Abnormalities in Acute Kawasaki Disease
NCT02179853
Pain Control for Intrauterine Device Placement Using Paracervical Block
NCT02219308
A Minimally-invasive Approach to Cytoreduction and HIPEC for Peritoneal Surface Malignancy
NCT02463877
Efficacy of ART to Interrupt HIV Transmission Networks
NCT02528773
Impact of Combined Behavioral Interventions on Cognitive Outcomes in MCI
NCT02864069
The Impact of Arousal Threshold in Obstructive Sleep Apnea
NCT02264353
Right Ventricular Hemodynamics Using Cardiac MRI in Patients COPD and OSA
NCT02244957
Alzheimer's Caregiver Coping: Mental and Physical Health
NCT02317523
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 80 |
| Phase 2 | 90 |
| Phase 3 | 22 |
| Phase 4 | 82 |
Therapeutic Areas
What is open in the University of California, San Diego pipeline
143 recruiting of 775 indexed (18% open); 499 completed (64%).
Phase mix: 104 late (III/IV) vs 170 early (I/II) (early-phase heavy).
Top condition: Anorexia Nervosa (10 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of California, San Diego: open-pipeline peers nationwide
Peers matched on 775 registered trials and 18% open enrollment, not the therapeutic-area sidebar.
University of California, San Diego sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 775 trials (± recruiting share)
- Dana-Farber Cancer Institute · 781 trials · 14% recruiting
- Medical University of South Carolina · 755 trials · 19% recruiting
- University of Chicago · 796 trials · 20% recruiting
- University of Utah · 818 trials · 17% recruiting
Sponsors near 18% open enrollment (± trial volume)
- Neurocrine Biosciences · 18% recruiting · 65 trials
- Thomas Jefferson University · 18% recruiting · 292 trials
- Abramson Cancer Center at Penn Medicine · 18% recruiting · 402 trials
- University of Maryland, Baltimore · 18% recruiting · 560 trials
Related
What to do with this University of California, San Diego page
775 registered trials is a research-attention snapshot, not an endorsement of University of California, San Diego or any single study.
- 143 of University of California, San Diego's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Anorexia Nervosa is the condition University of California, San Diego studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Anorexia Nervosa trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of California, San Diego pipeline card: 775 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.